Paolo Dellabona - Infectious Diseases

Author Information

Paolo Dellabona is affiliated with the Experimental Immunology Unit at the Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute in Milan, Italy. His work is centered around the field of immunology with a particular focus on infectious diseases and transplantation immunology.

Research Contributions

Paolo Dellabona's research has significantly contributed to the understanding of T cell responses, leukemia, and cancer immunotherapy. His recent work includes exploring the role of miR-21 in T-cell responses, engineering T cells for leukemia recognition, and deciphering immune responses in esophageal adenocarcinoma. He has also investigated the potential of CD1-restricted T cells for clinical benefits and cytokine-induced memory-like NK cells for adoptive immunotherapy.

Aliases

Paolo Dellabona is also known by the aliases P Dellabona and P. Dellabona in various publications and academic references.

Publication and Citation Metrics

Metric	Value
Total Citations	10,197
H-index	51
Total Papers	185

Publications:

miR‐21 sustains CD28 signalling and low‐affinity T‐cell responses at the expense of self‐tolerance

DOI: 10.1002/cti2.1321

Year: 2021

Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia

DOI: 10.1038/s41467-021-25223-0

Year: 2021

CD4+ T cells sustain aggressive chronic lymphocytic leukemia in Eμ-TCL1 mice through a CD40L-independent mechanism.

DOI: 10.1182/bloodadvances.2020003795

Year: 2021

Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells

DOI: 10.1002/eji.202049103

Year: 2021

Exploiting CD1-restricted T cells for clinical benefit.

DOI: 10.1016/j.molimm.2020.12.015

Year: 2021

P-158 Deciphering the immunological determinants of response to neoadjuvant chemo-radiation in esophageal adenocarcinoma

DOI: 10.1016/j.annonc.2021.05.213

Year: 2021

Cytokine-Induced Memory-Like NK Cells with High Reactivity against Acute Leukemia Blasts and Solid Tumor Cells Suitable for Adoptive Immunotherapy Approaches

DOI: 10.3390/cancers13071577

Year: 2021

Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia

DOI: 10.1158/1078-0432.CCR-20-1632

Year: 2020

NKT Cells in Cancer Immunotherapy

DOI: 10.3389/978-2-88963-933-5

Year: 2020

Mir106b-25 and Mir17-92 Are Crucially Involved in the Development of Experimental Neuroinflammation

DOI: 10.3389/fneur.2020.00912

Year: 2020

What is Flaviviridae?

What are Respiratory Symptoms?

What is Viral Mutation and Why is it Important?

What are the Recent Advances in Serological Testing?

How Do Fungal Pathogens Affect Us?

What are the clinical features of infections caused by Flaviviridae?

What is the Warburg Effect?

What are the Challenges in Managing Ebola?

How Does the NIH Collaborate with Other Organizations?

What is Malaria?

Partnered Content Networks

Relevant Topics